The Impact of Patient Capital on the Carbon Footprint of Bank Loans
An Analysis of Mediating Effects based on Bank Operational Risk
DOI:
https://doi.org/10.54691/ca41bv71Keywords:
Patient Capital; Commercial Banks; Loan Carbon Footprint; Operational Risk.Abstract
Patient capital's characteristics-including long-term investment and emphasis on sustainable development-align closely with carbon reduction principles, making it a potent driver for effectively lowering the carbon footprint of bank loans. Using a sample of 38 listed commercial banks in China's A-share market from 2010 to 2022 and employing a dual fixed-effects model, this study empirically examines the intrinsic relationship among patient capital, bank operational risk, and the carbon footprint of bank loans. Findings reveal: (1) Increasing the proportion of patient capital in the total equity of listed commercial banks significantly reduces the carbon footprint of bank loans. (2) Patient capital can lower the carbon footprint of bank loans by reducing bank operational risk. (3) This impact exhibits heterogeneity across bank asset size, ownership structure, and capital adequacy. Consequently, banks should leverage patient capital in a tailored manner to achieve a win-win outcome of green low-carbon transformation and risk prevention. Regulatory authorities should strengthen policy guidance and oversight to promote the role of patient capital in banking for green development.
Downloads
References
[1] IPCC. Climate change 2021:the physical science basis.Contribution of working group I to the Sixth assessment report of the intergovernmental panel on climate change[M].Cambridge University Press,2021.
[2] Teubler J, Kuehlert M. Financial carbon footprint: calculating banks' scope 3 emissions of assets and loans[C]. European Council for an Energy Efficient Economy, 2020.381-389.
[3] Z.Y. Jiang, F.X. Wu. Patient Capital, Digital Economy and Innovation Efficiency: Empirical Evidence Based on A-Share Listed Companies in Manufacturing Industry [J]. Journal of Hohai University(Philosophy and Social Sciences), 2024, 26(02): 121-133.
[4] M.J. Wu, P Zhang, Z.Y. Zhao. The Impact of Patient Capital and Innovation Investment on Corporate Performance:Based on the Data of Small and Medium-sized Board Listed Companies [J]. Scientific Decision Making, 2022(09):55-72.
[5] S.F. Li, L.Wen. Research on the Influence of Patience Capital on ESG Performance of Enterprises [J]. On Economic Problems, 2025(01):48-56.
[6] GUAN, RONG, ZHENG, HAITAO, HU, JIE, et al. The Higher Carbon Intensity of Loans, the Higher Non-Performing Loan Ratio: The Case of China[J]. Sustainability,2017,9(4):667.
[7] X. Deng, S.T. Gan, L.M. Chen. The impact of bank carbon risk on loan risk [J]. Systems Engineering-Theory & Practice, 2025, 45(02): 408-428.
[8] Z.H. Liu. The Logical Basis, Key Issues, and Practical Approaches for Strengthening Patient Capital in the Stage of High-Quality Development. [J]. Academic Journal of Zhongzhou, 2025, (01): 32-39.
[9] X.J. Chen, G. Yang, N. Wang. Carbon Risk Pricing: Evidence from China's Municipal Investment Bonds Market [J]. Contemporary Finance & Economics, 2024, (12): 54-67. DOI: 10.13676/j.cnki.cn36-1030/f.20240802.001.
[10] L. Tang, G.Y. Yang. A Study of the Impact of Patient Capital Investment on Corporate ESG Performance [J]. China Business and Market,2025,39(02):86-99.
[11] Ivashina V ,Lerner J .Patient Capital:The Challenges and Promises of Long-Term Investing[M]. Princeton University Press:2019-01-01
[12] H.R. Wei, J Zhang. Digital Enabling, Environmental Regulation and Green Transformation of Manufacturing Enterprises [J/OL]. Collected Essays on Finance and Economics,1-16. [2025-7-27].https://doi.org/10.13762/j.cnki.cjlc.20250513.003.
[13] Y.F. Zhang, M.F. Lu. Patient Capital and High Quality Development: Attribute Characteristics, Reality and Countermeasures[J]. Journal of Financial Development Research,2024,(11):88-92.
[14] D.N. Ren, L.J. Zheng. Carbon Emission Intensity of Credit,Green Finance and Business Performance of Commercial Banks [J]. Journal of Regional Financial Research,2023(05):66-73.
[15] G.Y. Yang, L. Tang. The Impact of Patient capital on Business Resilience[J]. Finance & Economics,2025(03):15-29.
[16] T. Jiang. Mediating Effects and Moderating Effects in Causal Inference[J]. China Industrial Economics,2022(05):100-120.
[17] W.B. He, M.X. Gong. Can Patient Capital Alleviate Overcapacity?--From the Perspective of Capacity Utilization Rate of Listed Companies[J]. Contemporary Economic Research,2025(01):85-100.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Scientific Journal of Economics and Management Research

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.




